Ask a handful of research-compound sellers whether they carry product liability insurance and the honest answer, more often than buyers assume, is no — not because they’ve decided against it, but because most mainstream commercial insurers won’t write a policy for an unapproved compound marketed for off-label human use.

Why Insurers Decline the Category

That risk category doesn’t map cleanly onto anything most insurers are willing to price. Some specialty underwriters will write coverage, at smaller scale and higher cost than a conventional product would face.

“A lot of sellers in this space are personally exposed if something goes wrong. Buyers usually have no way of knowing which ones.”

— an insurance broker who works with specialty and high-risk commercial clients

What This Means When Something Goes Wrong

A seller with no liability coverage has fewer resources to draw on if a product causes harm — the seller’s own assets, rather than an insurer’s, are what’s actually exposed.

A Rough Way to Read a Seller’s Risk Posture

Sellers who carry coverage and documented quality processes tend to operate more conservatively across the board — a real structural difference buyers generally can’t see.